Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
FASEB J ; 36(10): e22558, 2022 10.
Article in English | MEDLINE | ID: mdl-36165222

ABSTRACT

Oncogenic reprogramming of cellular metabolism is a hallmark of many cancers, but our mechanistic understanding of how such dysregulation is linked to tumor behavior remains poor. In this study, we have identified dihydroceramide desaturase (DES1)-which catalyzes the last step in de novo sphingolipid synthesis-as necessary for the acquisition of anchorage-independent survival (AIS), a key cancer enabling biology, and establish DES1 as a downstream effector of HER2-driven glucose uptake and metabolism. We further show that DES1 is sufficient to drive AIS and in vitro tumorigenicity and that increased DES1 levels-found in a third of HER2+ breast cancers-are associated with worse survival outcomes. Taken together, our findings reveal a novel pro-tumor role for DES1 as a transducer of HER2-driven glucose metabolic signals and provide evidence that targeting DES1 is an effective approach for overcoming AIS. Results further suggest that DES1 may have utility as a biomarker of aggressive and metastasis-prone HER2+ breast cancer.


Subject(s)
Breast Neoplasms , Oxidoreductases , Biological Transport , Female , Glucose , Humans , Oxidoreductases/metabolism , Sphingolipids
2.
J Lipid Res ; 60(11): 1841-1850, 2019 11.
Article in English | MEDLINE | ID: mdl-31243119

ABSTRACT

Sphingolipids contribute to the regulation of cell and tissue homeostasis, and disorders of sphingolipid metabolism lead to diseases such as inflammation, stroke, diabetes, and cancer. Sphingolipid metabolic pathways involve an array of enzymes that reside in specific subcellular organelles, resulting in the formation of many diverse sphingolipids with distinct molecular species based on the diversity of the ceramide (Cer) structure. In order to probe compartment-specific metabolism of sphingolipids in this study, we analyzed the Cer and SM species preferentially produced in the inner plasma membrane (PM), Golgi apparatus, ER, mitochondria, nucleus, and cytoplasm by using compartmentally targeted bacterial SMases and ceramidases. The results showed that the length of the acyl chain of Cer becomes longer according to the progress of Cer from synthesis in the ER to the Golgi apparatus, then to the PM. These findings suggest that each organelle shows different properties of SM-derived Cers consistent with its emerging distinct functions in vitro and in vivo.


Subject(s)
Ceramidases/metabolism , Sphingolipids/metabolism , Sphingomyelin Phosphodiesterase/metabolism , Cell Line , Ceramides/metabolism , Endoplasmic Reticulum/metabolism , Golgi Apparatus/metabolism , Humans
3.
Cell Metab ; 25(3): 686-697, 2017 03 07.
Article in English | MEDLINE | ID: mdl-28273483

ABSTRACT

In an approach aimed at defining interacting partners of ceramide synthases (CerSs), we found that fatty acyl-CoA synthase ACSL5 interacts with all CerSs. We demonstrate that ACSL5-generated FA-CoA was utilized with de novo ceramide for the generation of acylceramides, poorly studied ceramide metabolites. Functionally, inhibition of ceramide channeling to acylceramide enhanced accumulation of de novo ceramide and resulted in augmentation of ceramide-mediated apoptosis. Mechanistically, we show that acylceramide generation is catalyzed by diacylglycerol acyltransferase 2 (DGAT2) on lipid droplets. In summary, this study identifies a metabolic pathway of acylceramide generation and its sequestration in LDs in cells and in livers of mice on a high-fat diet. The study also implicates this pathway in ceramide-mediated apoptosis, and has implications in co-regulation of triglyceride and sphingolipid metabolisms.


Subject(s)
Ceramides/metabolism , Lipid Droplets/metabolism , Acylation , Animals , Coenzyme A Ligases/chemistry , Coenzyme A Ligases/metabolism , Diacylglycerol O-Acyltransferase/metabolism , Diet, High-Fat , Feeding Behavior , Gene Silencing , HCT116 Cells , Humans , Liver/metabolism , Mice, Inbred C57BL , Oxidoreductases/metabolism , Protein Domains , Substrate Specificity
4.
J Neurosci ; 33(23): 9840-5, 2013 Jun 05.
Article in English | MEDLINE | ID: mdl-23739980

ABSTRACT

Most fast excitatory synaptic transmission in the nervous system is mediated by glutamate acting through ionotropic glutamate receptors (iGluRs). iGluRs (AMPA, kainate, and NMDA receptor subtypes) are tetrameric assemblies, formed as a dimer of dimers. Still, the mechanism underlying tetramerization--the necessary step for the formation of functional receptors that can be inserted into the plasma membrane--is unknown. All eukaryotic compared to prokaryotic iGluR subunits have an additional transmembrane segment, the M4 segment, which positions the physiologically critical C-terminal domain on the cytoplasmic side of the membrane. AMPA receptor (AMPAR) subunits lacking M4 do not express on the plasma membrane. Here, we show that these constructs are retained in the endoplasmic reticulum, the major cellular compartment mediating protein oligomerization. Using approaches to assay the native oligomeric state of AMPAR subunits, we find that subunits lacking M4 or containing single amino acid substitutions along an "interacting" face of the M4 helix that block surface expression no longer tetramerize in either homomeric or heteromeric assemblies. In contrast, subunit dimerization appears to be largely intact. These experiments define the M4 segment as a unique functional unit in AMPARs that is required for the critical dimer-to-tetramer transition.


Subject(s)
Eukaryotic Cells/chemistry , Protein Multimerization/physiology , Receptors, AMPA/chemistry , Animals , Cell Membrane/chemistry , Cell Membrane/physiology , Eukaryotic Cells/physiology , HEK293 Cells , Humans , Protein Structure, Secondary , Protein Subunits/chemistry , Protein Subunits/physiology , Rats , Receptors, AMPA/physiology
5.
J Neurosci ; 24(32): 7186-93, 2004 Aug 11.
Article in English | MEDLINE | ID: mdl-15306652

ABSTRACT

Identification of conserved proteins that act to establish the neuronal phenotype has relied predominantly on structural homologies of the underlying genes. In the case of the repressor element 1 silencing transcription factor (REST), a central player in blocking the neuronal phenotype in vertebrate non-neural tissue, the invertebrate homolog is absent, raising the possibility that distinct strategies are used to establish the CNS of invertebrates. Using a yeast two-hybrid screen designed specifically to identify functional analogs of REST, we show that Drosophila melanogaster uses a strategy that is functionally similar to, but appears to have evolved independently of, REST. The gene at the center of the strategy in flies encodes the repressor Tramtrack88 (Ttk88), a protein with no discernable homology to REST but that nonetheless is able to interact with the same transcriptional partners. Ttk88 uses the REST corepressor Drosophila CoREST to coordinately regulate a set of genes encoding the same neuronal hallmarks that are regulated by REST in vertebrates. Our findings indicate that repression is an important mechanism for regulating neuronal phenotype across phyla and suggest that co-option of a similar corepressor complex occurred to restrict expression of genes critical for neuronal function to a compartmentalized nervous system.


Subject(s)
Central Nervous System/embryology , Co-Repressor Proteins/genetics , DNA-Binding Proteins/genetics , Drosophila Proteins/genetics , Drosophila/genetics , Nerve Tissue Proteins/genetics , Repressor Proteins/genetics , Transcription Factors/genetics , Amino Acid Sequence , Animals , Cell Line , Co-Repressor Proteins/biosynthesis , Co-Repressor Proteins/physiology , Conserved Sequence , DNA-Binding Proteins/biosynthesis , Drosophila Proteins/biosynthesis , Drosophila Proteins/physiology , Drosophila melanogaster/embryology , Drosophila melanogaster/genetics , Drosophila melanogaster/metabolism , Humans , Larva , Mice , Nerve Tissue Proteins/biosynthesis , Neurons/metabolism , Repressor Proteins/biosynthesis , Repressor Proteins/physiology , Two-Hybrid System Techniques
SELECTION OF CITATIONS
SEARCH DETAIL
...